HealthQuad has announced the first close of its third fund with ₹550 crore in commitments, giving fresh momentum to startups building the future of healthcare in India.
Health-focused venture capital firm HealthQuad has announced the first close of its third fund, securing ₹550 crore in commitments more than a third of its targeted corpus. At a time when startup funding remains selective, the successful close suggests healthcare is still one of the sectors investors are willing to back for the long haul.
The new fund has attracted backing from both existing and new limited partners, including domestic and global institutions, fund-of-funds, and family offices. HealthQuad has also wasted little time putting money to work, making its first investment in Lifesigns, an AI-powered remote patient monitoring platform.
Since launching in 2016, HealthQuad has emerged as one of the few firms focused exclusively on healthcare innovation. Over the years, it has backed startups such as Qure.ai, Redcliffe Labs, Wysa, CureSkin, and Medikabazaar, many of which have gone on to become category leaders.
Fund III will focus on early-growth companies operating across healthtech, medtech, biopharma technology, and new healthcare delivery models. These are segments that are expected to account for a significant share of India's rapidly expanding healthcare market over the next decade.
At a time when venture funding remains selective, HealthQuad's latest milestone is a reminder that investors continue to place long-term bets on startups solving real-world healthcare challenges.
If the first close is any indication, healthcare startups solving real problems may continue to find willing backers even in a tougher funding mark
Filed by
Startup Unplugged
